L’Hôtel-Dieu de Paris est un établissement hospitalier construit de 1867 à 1878 sous la conduite des architectes Émile Jacques Gilbert et Arthur-Stanislas Diet sur l'île de la Cité, en bordure nord du parvis Notre-Dame dans le 4ᵉ arrondissement de Paris.

During the past decade, Hopital Hotel Dieu conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 8 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 6 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Hotel Dieu" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 15 trials, followed by "ARCAGY/ GINECO GROUP" with 14 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 14 trials sponsored, "ANRS, Emerging Infectious Diseases" with 12 trials sponsored and "Groupe Francophone des Myelodysplasies" with 12 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Hotel Dieu" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "European Georges Pompidou Hospital" with 2 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Institut Pasteur" with 2 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Hotel Dieu" are "Leukemia" (9 trials), "Ovarian Cancer" (8 trials), "Fallopian Tube Cancer" (6 trials), "Lymphoma" (6 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Hopital Hotel Dieu" in a lesser frequency.

Most popular intervention types in "Hopital Hotel Dieu" are "Drug" (71 trials), "Other" (17 trials), "Biological" (11 trials), "Procedure" (10 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "cytarabine" (7 trials), "idarubicin" (7 trials), "etoposide" (6 trials) and "radiation therapy" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Hotel Dieu" are 79 trials for "All" genders, 24 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 19 active trials in "Hopital Hotel Dieu". 4 are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 65 completed trials in Hopital Hotel Dieu, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Hotel Dieu, 1 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 20 trials that are defined as “Not Applicable".